美國居民不適用 XM 服務。
A
A

Agilent

交易方向

交易者脈動

技術摘要

小時

財經新聞

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Mattel, Tellurian Updates: Clearwater Paper, Agilent July 22 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1955 GMT on Monday: * * L Catterton, the private equity firm backed by luxury goods giant LVMH LVMH.PA , has approached Mattel MAT.O , the toy maker behind Barbie and Hot Wheels, with an acquisition offer, people familiar with the matter said.
A
G
H
L
M
V
D

Agilent Technologies To Acquire BIOVECTRA for $925 Million

BRIEF-Agilent Technologies To Acquire BIOVECTRA for $925 Million July 22 (Reuters) - Agilent Technologies Inc A.N : AGILENT TO ACQUIRE NORTH AMERICAN CDMO BIOVECTRA AGILENT TECHNOLOGIES INC - TO ACQUIRE BIOVECTRA FOR $925 MILLION AGILENT TECHNOLOGIES INC - EXPECTS ACQUISITION TO BE $0.05 DILUTIVE TO NON-GAAP EPS Source text for Eikon: ID:nBw5TcW1Fa
A

Agilent to buy contract drug manufacturer Biovectra for $925 mln

UPDATE 2-Agilent to buy contract drug manufacturer Biovectra for $925 mln Adds deal details in paragraph 5 and background throughout July 22 (Reuters) - Agilent Technologies A.N said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
A

Agilent to buy contract drug manufacturer Biovectra for $925 million

Agilent to buy contract drug manufacturer Biovectra for $925 million July 22 (Reuters) - Medical equipment maker Agilent Technologies A.N said on Monday it will acquire privately held contract drug manufacturer Biovectra for $925 million. Reporting by Mariam Sunny in Bengaluru; Editing by Shounak Dasgupta
A

U.S. Elevance Health, J&J, Primerica

U.S. RESEARCH ROUNDUP-Elevance Health, J&J, Primerica July 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Elevance Health, J&J and Primerica, on Thursday. HIGHLIGHTS * Elevance Health Inc ELV.N : Leerink Partners cuts target price to $620 from $630 * J&J JNJ.N : TD Cowen cuts target price to $185 from $195 * Primerica Inc PRI.N : Jefferies raises target price to $249 from $239 * Travelers Companies Inc TRV.N : HS
A
A
O
P
Q
A
A
C

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明